S

Sds Optic SA
WSE:SDS

Watchlist Manager
Sds Optic SA
WSE:SDS
Watchlist
Price: 6.3 PLN 5% Market Closed
Market Cap: zł39.7m

Net Margin

-6.5%
Current
Improving
by 505 974.7%
vs 3-y average of -505 981.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-6.5%
=
Net Income
zł-483.7k
/
Revenue
zł7.4m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-6.5%
=
Net Income
zł-483.7k
/
Revenue
zł7.4m

Peer Comparison

Country Company Market Cap Net
Margin
PL
Sds Optic SA
WSE:SDS
36.8m PLN
Loading...
US
Abbott Laboratories
NYSE:ABT
190.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
140.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
131.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.1B USD
Loading...

Market Distribution

Lower than 73% of companies in Poland
Percentile
27th
Based on 886 companies
27th percentile
-6.5%
Low
-9 940 700% — -3.7%
Typical Range
-3.7% — 9.1%
High
9.1% — 196 605.3%
Distribution Statistics
Poland
Min -9 940 700%
30th Percentile -3.7%
Median 2.9%
70th Percentile 9.1%
Max 196 605.3%

Sds Optic SA
Glance View

Market Cap
39.7m PLN
Industry
Health Care

SDS Optic SA engages in the development of biochemistry, engineering, and fiber optic technologies solutions, which can be used in cancer diagnosis and treatment. The company is headquartered in Lublin, Woj. Lubelskie. The company went IPO on 2022-03-15. The Company’s primary research activity relates to the oncology sector. The Firm wishes to develop a method for early breast cancer diagnosis. The current method of diagnosis relies on biopsy and histopathology. The purpose of the tests is to identify cancer markers. The firm tries to implement InProbe method, which is faster and more accurate- the method should be able to provide results within 20 minutes. The firm is also engaged in research regarding different kinds of diseases such as fungal diseases. The firm cooperates with specialists from different fields such as biology, medicine, technology, and sciences related to medicine.

SDS Intrinsic Value
3.89 PLN
Overvaluation 38%
Intrinsic Value
Price
S
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-6.5%
=
Net Income
zł-483.7k
/
Revenue
zł7.4m
What is Sds Optic SA's current Net Margin?

The current Net Margin for Sds Optic SA is -6.5%, which is above its 3-year median of -505 981.2%.

How has Net Margin changed over time?

Over the last 3 years, Sds Optic SA’s Net Margin has increased from -386.7% to -6.5%. During this period, it reached a low of -4 750 000% on Sep 30, 2024 and a high of -6.5% on Oct 30, 2025.

Back to Top